RethinkPeptides
ArticlesTopicsResearch

Ocular Peptides

3 articles in this topic.

Complete Guides

Ocular PeptidesGuide

Lacritin: The Tear Peptide for Dry Eye

Lacritin is the only known prosecretory tear protein. From 2001 discovery to 2023 human trial, the science of this peptide therapy for dry eye disease.

20 min read|Mar 20, 2026
Ocular PeptidesGuide

Pegaptanib: The First Anti-VEGF Agent Approved for Eyes

Pegaptanib (Macugen) was the first anti-VEGF and first aptamer drug approved by the FDA in 2004. How it worked, why ranibizumab replaced it, and its legacy.

20 min read|Mar 20, 2026

All Articles

Ocular Peptides

Peptide Therapies for Macular Degeneration

Peptide therapies for AMD include anti-VEGF peptide eye drops, integrin inhibitors, neuroprotective peptides, and GLP-1 agonists that may reduce AMD risk.

13 min read|Mar 25, 2026

RethinkPeptides

Evidence-based peptide education. No hype, no sales. Just science.

Navigate

All ArticlesTopicsResearch DatabaseEvidence MethodologyDownload DataSearch

About

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of Use

Disclaimer

Content on RethinkPeptides is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Peptides discussed here may not be approved for human use in your jurisdiction.

© 2026 RethinkPeptides. All rights reserved.